Memphis Neurology participates regularly in a wide variety of clinical studies. Some of our current ones include the effects of the following drugs:

• Brivaracetam: 16 to 75 year olds with partial onset seizures with or without secondary generalization. The primary objective of this study is to evaluate the efficacy of Brivaracetam in the conversion to monotherapy at the doses of 50 and 100mg/day in subjects with partial onset seizures when compared to a historical pseudo-placebo control group.

• Future studies: A study on children with absence seizures (Petit Mal seizures), a seizure study on Vagal Nerve Stimulation. A study with patients over three years old diagnosed with Cerebal Palsy and excessive drooling. A study with patients who have one to six migraines per month.